MODV stock plunges to 52-week low, touches $1.02

Published 09/04/2025, 16:14
MODV stock plunges to 52-week low, touches $1.02

In a stark reflection of investor sentiment, ModivCare Inc. (MODV) stock has plummeted near its 52-week low of $1.06, trading at $1.10. With a market capitalization now at just $15.8 million and carrying a substantial debt burden of $1.3 billion, the company faces significant challenges. According to InvestingPro analysis, the stock's RSI indicates oversold territory. This significant downturn marks a distressing period for the company, as it grapples with market challenges that have eroded its stock value over the past year. The 1-year change data paints a grim picture, with The Providence Service Corporation, ModivCare's parent company, witnessing a staggering -95.41% decline. This sharp decrease underscores the volatility and the tough market conditions the company has faced, shaking the confidence of shareholders and stakeholders alike. Analyst targets range from $2.25 to $12.00, though InvestingPro subscribers can access 18 additional key insights about MODV's financial health and future prospects through the comprehensive Pro Research Report.

In other recent news, ModivCare Inc. reported its fourth-quarter and full-year 2024 financial results, missing both earnings per share (EPS) and revenue forecasts. The company's Q4 EPS was $0.19, falling short of the projected $0.76, and revenue was $702.8 million, below the expected $718.94 million. Despite these misses, ModivCare has made strategic moves, including finalizing a debt restructuring deal, exchanging $251 million in senior notes for second lien senior secured PIK toggle notes. This debt restructuring is part of ModivCare's broader strategy to manage its financial obligations effectively. Additionally, the company secured a new financial agreement, issuing $50.165 million of Second Lien Senior Secured PIK Toggle Notes due 2029. Stephens analysts recently adjusted their outlook on ModivCare, reducing the price target to $3.50 from $7.00, while maintaining an Equal Weight rating on the stock. These developments highlight ModivCare's efforts to navigate financial challenges and strategic transitions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.